Economic analysis: randomized placebo-controlled clinical trial of erlotinib in advanced non–small cell lung cancer

PA Bradbury, D Tu, L Seymour, PK Isogai… - Journal of the …, 2010 - academic.oup.com
Abstract Background The NCIC Clinical Trials Group conducted the BR. 21 trial, a
randomized placebo-controlled trial of erlotinib (an epidermal growth factor receptor tyrosine …
被引用次数：84 相关文章
[PDF] archive.org

[PDF][PDF] economic Analysis: randomized Placebo-controlled clinical trial of erlotinib in Advanced Non–Small cell lung cancer

PA Bradbury, D Tu, L Seymour, PK Isogai… - J Natl Cancer …, 2010 - scholar.archive.org
Background The NCIC Clinical Trials Group conducted the BR. 21 trial, a randomized
placebo-controlled trial of erlotinib (an epidermal growth factor receptor tyrosine kinase …

Economic analysis: randomized placebo-controlled clinical trial of erlotinib in advanced non-small cell lung cancer

PA Bradbury, D Tu, L Seymour… - Journal of the …, 2010 - pubmed.ncbi.nlm.nih.gov
Background The NCIC Clinical Trials Group conducted the BR. 21 trial, a randomized
placebo-controlled trial of erlotinib (an epidermal growth factor receptor tyrosine kinase …
[PDF] researchgate.net

[PDF][PDF] economic Analysis: randomized Placebo-controlled clinical trial of erlotinib in Advanced Non–Small cell lung cancer

PA Bradbury, D Tu, L Seymour, PK Isogai, L Zhu… - J Natl Cancer …, 2010 - researchgate.net
Background The NCIC Clinical Trials Group conducted the BR. 21 trial, a randomized
placebo-controlled trial of erlotinib (an epidermal growth factor receptor tyrosine kinase …

Economic analysis: randomized placebo-controlled clinical trial of erlotinib in advanced non-small cell lung cancer.

PA Bradbury, D Tu, L Seymour, PK Isogai… - Journal of the …, 2010 - europepmc.org
Background The NCIC Clinical Trials Group conducted the BR. 21 trial, a randomized
placebo-controlled trial of erlotinib (an epidermal growth factor receptor tyrosine kinase …

[引用][C] Economic Analysis: Randomized Placebo-Controlled Clinical Trial of Erlotinib in Advanced Non-Small Cell Lung Cancer

PA BRADBURY, D TU, NB LEIGHL… - Journal of the …, 2010 - pascal-francis.inist.fr
Economic Analysis: Randomized Placebo-Controlled Clinical Trial of Erlotinib in Advanced
Non-Small Cell Lung Cancer CNRS Inist Pascal-Francis CNRS Pascal and Francis …
[PDF] academia.edu

[PDF][PDF] Economic Analysis: Randomized Placebo-Controlled Clinical Trial of Erlotinib in Advanced Non–Small Cell Lung Cancer

PA Bradbury, D Tu, L Seymour, PK Isogai, L Zhu… - J Natl Cancer …, 2010 - academia.edu
Background The NCIC Clinical Trials Group conducted the BR. 21 trial, a randomized
placebo-controlled trial of erlotinib (an epidermal growth factor receptor tyrosine kinase …

Economic Analysis: Randomized Placebo-Controlled Clinical Trial of Erlotinib in Advanced Non–Small Cell Lung Cancer.

PA Bradbury, D Tu, L Seymour… - JNCI: Journal of the …, 2010 - search.ebscohost.com
Abstract Background: The NCIC Clinical Trials Group conducted the BR. 21 trial, a
randomized placebo-controlled trial of erlotinib (an epidermal growth factor receptor tyrosine …
[PDF] academia.edu

[PDF][PDF] Economic Analysis: Randomized Placebo-Controlled Clinical Trial of Erlotinib in Advanced Non–Small Cell Lung Cancer

PA Bradbury, D Tu, L Seymour, PK Isogai, L Zhu… - J Natl Cancer …, 2010 - academia.edu
Background The NCIC Clinical Trials Group conducted the BR. 21 trial, a randomized
placebo-controlled trial of erlotinib (an epidermal growth factor receptor tyrosine kinase …

[引用][C] Economic Analysis: Randomized Placebo-Controlled Clinical Trial of Erlotinib in Advanced Non-Small Cell Lung Cancer

PA BRADBURY, TU DONGSHENG… - Journal of the …, 2010 - Oxford University Press